Search Results 301-310 of 28460 for liver disease

  1. Mayo Clinic identifies factors to predict mortality in pediatric liver transplant

    The current system of prioritizing children with liver disease who are waiting for transplantation may not be optimal because the Pediatric End-stage Liver ...

  2. Study to Check the Safety of Fazirsiran and Learn if Fazirsiran Can Help People With Liver Disease and Scarring (Fibrosis) Due to an Abnormal Version of Alpha-1 Antitrypsin Protein - Mayo Clinic

    Study to Check the Safety of Fazirsiran and Learn if Fazirsiran Can Help People With Liver Disease and Scarring (Fibrosis) Due to an Abnormal Version of ...

  3. Combination Therapy Offers Quicker, Less Toxic Eradication of Hepatitis C in Patients with Transplanted Livers - Mayo Clinic News Network

    Most infected people have no symptoms of the disease until liver damage from chronic inflammation occurs decades later — which happens to 5–30 percent of ...

  4. Drinking alcohol: Is it safe after hepatitis C cure? - Mayo Clinic

    Liver cancer risk. Hepatitis C-related liver damage increases your risk of liver cancer. Fortunately, eradication of the hepatitis C virus via DAA treatment ...

  5. Samar H. Ibrahim, M.B., Ch.B. - Doctors and Medical Staff - Mayo Clinic

    Her primary clinical interests are steatohepatitis, cholestatic liver diseases, acute liver failure and liver transplantation. ... Nonalcoholic fatty liver ...

  6. Pancreatic cancer - Symptoms and causes - Mayo Clinic

    Pancreatic cancer that blocks the liver's bile duct can cause jaundice. ... Digestive and Liver Disease. 2015;47:495. Pancreatic cancer: Symptoms and ...

  7. Nonalcoholic fatty liver disease - Doctors and departments - Mayo Clinic

    Mayo Clinic researchers seek to understand why some people with nonalcoholic fatty liver disease develop cirrhosis but others do not. Publications. See a ...

  8. Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing an Elective Procedure - Mayo Clinic

    ... liver disease. The study will evaluate avatrombopag in the treatment of thrombocytopenia associated with liver disease prior to an elective procedure to ...

  9. A study to test whether survodutide helps people with a liver disease called NASH/MASH who have cirrhosis - Mayo Clinic

    placebo on liver-related outcome events and all-cause mortality in participants with compensated MASH cirrhosis. Participation eligibility. Participant ...

  10. Consuming Coffee Linked to Lower Risk of Detrimental Liver Disease - Mayo Clinic News Network

    Regular consumption of coffee is associated with a reduced risk of primary sclerosing cholangitis (PSC), an autoimmune liver disease, Mayo Clinic research ...